期刊文献+

H_2O_2氧化刺激对紫杉醇耐药和敏感肺癌细胞的不同影响 被引量:2

The different reactions of chemo-resistant and chemo-sensitive lung adenocarcinoma cells to redox stimulation of H_2O_2
原文传递
导出
摘要 目的:探讨人肺腺癌细胞株A549及紫杉醇(paclitaxel)耐药细胞株A549/Taxol对于H2O2氧化刺激的不同反应性及可能的作用机制。方法:用不同浓度的H2O2处理A549及A549/Taxol细胞后,采用细胞计数试剂盒-8(cell counting kit-8,CCK-8)检测细胞存活率,并计算半数细胞抑制浓度(half inhibitory concentration,IC50)值;采用荧光探针氯甲基-2’,7’-二氯二氢荧光素二乙酯[5-(and-6)-chloromethyl-2’,7’-dichlorouorescein diacetateacctyl ester,CM-H2DCFDA]染色法检测细胞内活性氧(reactive oxygen species,ROS)水平;四甲基罗丹明甲酯(tetramethylrhodamine methyl ester perchlorate,TMRM)染色法检测细胞线粒体膜电位水平;AnnexinⅤ-FITC/PI双染法检测细胞凋亡率;实时荧光定量-PCR法检测细胞内超氧化物歧化酶1(superoxide dismutase1,SOD1)、SOD2、过氧化氢酶(catalase,CAT)、γ-谷氨酰半胱氨酸链接酶(glutamate-cysteineligase,GCL)、谷胱甘肽合成酶(glutathione synthetase,GSS)和谷胱甘肽还原酶(glutathione reductase,GSR)mRNA表达的变化。结果:耐药细胞株A549/Taxol对H2O2的IC50值高于亲本细胞株A549;采用低毒浓度H2O2(50和100μmol/L)作用2h后,A549/Taxol细胞中的ROS水平增高幅度显著低于A549细胞,A549/Taxol细胞的线粒体膜电位保持相对稳定而A549细胞显著增高,且A549/Taxol细胞的凋亡发生率显著低于A549细胞。A549/Taxol细胞中抗氧化系统相关基因SOD1、SOD2、CAT、GCL、GSS和GSRmRNA的表达量高于A549细胞;在H2O2作用后,A549细胞中上述基因表达量显著增高,而A549/Taxol细胞中仅GSRmRNA表达上调。结论:紫杉醇耐药细胞对氧化刺激的耐受能力显著高于敏感细胞株,其机制可能与耐药细胞自身氧化-还原平衡系统的适应性变化有关。 Objective: To investigate the different reactions of paclitaxel-resistant subline A549/Taxol and its parental sensitive cell line A549 to redox stimulation of H202 and to explore its possible mechanism. Methods: Both A549/Taxol and A549 cell lines were treated with different concentrations of H202. The survival rate of the cells was determined by CCK-8 (cell counting kit-8) assay and the ICso (half inhibitory concentration) value of H202 was calculated. The change of intracellular ROS (reactive oxygen species) level was detected by using CM-H2DCFDA [5-(and-6)-chloromethyl-2',7'-dichlorodihydrofluorescein diacetate acetyl ester] staining assay. The mitochondrial membrane potential level was examined by TMRM (tetramethylrhodamine methyl ester) staining assay. The apoptosis rate was examined by AnnexinY-FITC/ PI double staining. The changes of mRNA levels of anti-redox-related genes including SOD1 (superoxide dismutase 1), SOD2, CAT (catalase), GCL (glutamate-cysteine ligase), GSS (glutathione synthetase) and GSR (glutathione reductase) were detected by real-time fluorescence-based quantitative PCR. Results: The ICs0 value of A549/Taxol cells was significantly lower than that of A549 cells after redox stimulation of H202. After short-term 2 h treatment with low dose of H202 (50 and 100 IJmol/L), the increasing degree of ROS level in A549 cells was significantly higher than that in A549/Taxol cells, the mitochondrial membranepotential of A549/Taxol cells remained relatively stable while that of A549 cells rised significantly, and the apoptosis rate of A549/Taxol cells was significantly lower than that of A549 cells. The mRNA expression levels of anti-redox-related genes including SOD1, SOD2, CAT, GCL, GSS and GSR were higher in A549/ Taxol cells than those in A549 cells. The expression levels of these genes were increased significantly in A549 cells, but in A549/Taxol cells, only the expression level of GSR mRNA was increased slightly after redox stimulation of H202. Conclusion: The resistant ability to redox stimulation for paclitaxel-resistant A549/Taxol cells was significantly stronger than of parental sensitive A549 cells. This mechanism may be associated with the adaptive balancinq of oxidation-reduction system in A549/Taxol cells.
出处 《肿瘤》 CAS CSCD 北大核心 2013年第5期415-421,共7页 Tumor
基金 国家自然科学基金资助项目(编号:30970842)
关键词 非小细胞肺 紫杉醇 抗药性 肿瘤 氧化性应激 Carcinoma, non-small cell lung Paclitaxel Drug resistance, neoplasm Oxidative stress
  • 相关文献

参考文献4

二级参考文献55

  • 1Ryung-Ah Lee,Hyun-Ah Kim,Bo-Young Kang,Kwang-Ho Kim.Hemoglobin induces colon cancer cell proliferation by release of reactive oxygen species[J].World Journal of Gastroenterology,2006,12(35):5644-5650. 被引量:1
  • 2李晓宇,王同杉,李楠,佟仲生,刘平,陈琪,巴一.Cyclin L2在化疗诱导肝癌细胞凋亡中的作用[J].江苏医药,2007,33(5):471-473. 被引量:1
  • 3Jordan MA,Kamath K.How do microtubule-targeted drugs work? An overview[J].Curr Cancer Drug Targets,2007,7(8):730-742.
  • 4Sève P,Dumontet C.Chemoresistance in non-small cell lung cancer[J].Curr Med Chem Anticancer Agents,2005,5(1):73-88.
  • 5Yusuf RZ,Duan Z,Lamendola DE,et al.Paclitaxel resistance:molecular mechanisms and pharmacologic manipulation[J].Curr Cancer Drug Targets,2003,3(1):1-19.
  • 6Le Moguen K,Lincet H,Deslandes E,et al.Comparative proteomic analysis of cisplatin sensitive IGROV1 ovarian carcinoma cell line and its resistant counterpart IGROV1-R10[J].Proteomics,2006,6(19):5183-5192.
  • 7González-Santiago L,Alfonso P,Suárez Y,et al.Proteomic analysis of the resistance to aplidin in human cancer cells[J].J Proteome Res,2007,6(4):1286-1294.
  • 8Besada V,Diaz M,Becker M,et al.Proteomics of xenografted human breast cancer indicates novel targets related to tamoxifen resistance[J].Proteomics,2006,6(3):1038-1048.
  • 9Zhang JT,Liu Y.Use of comparative proteomics to identify potential resistance mechanisms in cancer treatment[J].Cancer Treat Rev,2007,33(8):741-756.
  • 10Luqmani YA.Mechanisms of drug resistance in cancer chemotherapy[J].Med Princ Pract,2005,14(Suppl 1):S35-S48.

共引文献17

同被引文献19

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部